Offer - Urjas Oil for just ₹ 1 X
Aztrone 500 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Bacterial Infections, Cystic Fibrosis. The alternative uses of Aztrone 500 Injection have also been explained below.
The optimal dosage of Aztrone 500 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
While these are the most often observed Aztrone 500 Injection side effects, there are can be others also. These have been listed below. These side effects of Aztrone 500 Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Aztrone 500 Injection's effect is Safe during pregnancy and Safe for lactating mothers. It is important to know if Aztrone 500 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Aztrone 500 Injection related warnings section.
Aztrone 500 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. Some other conditions that can be affected by Aztrone 500 Injection are listed in the contraindications section below.
Besides this, Aztrone 500 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Aztrone 500 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Aztrone 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Aztrone 500 Injection safe for pregnant women?
Aztrone is safe to take during pregnancy.
Is the use of Aztrone 500 Injection safe during breastfeeding?
Breastfeeding women can safely use Aztrone.
What is the effect of Aztrone 500 Injection on the Kidneys?
Aztrone rarely harms the kidneys.
What is the effect of Aztrone 500 Injection on the Liver?
Aztrone does not damage the liver.
What is the effect of Aztrone 500 Injection on the Heart?
Using Aztrone does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Aztrone 500 Injection unless your doctor advises you to do so -
Is this Aztrone 500 Injection habit forming or addictive?
No, there is no any evidence that Aztrone 500 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Aztrone 500 Injection as you may feel sleepy.
Is it safe?
Aztrone 500 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Aztrone 500 Injection in mental disorders is not effective.
Interaction between Food and Aztrone 500 Injection
Taking Aztrone 500 Injection with food does not harm your health.
Interaction between Alcohol and Aztrone 500 Injection
Information about the interaction of Aztrone 500 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azactam® (aztreonam)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 730